Sandoz Debuts US Combigan Rival
Follows Apotex Launch Of Authorized Generic Earlier This Year
Sandoz has expanded its ophthalmic portfolio with the introduction of the first US generic rival to Combigan. However, the firm will have to contend with an authorized generic launched earlier this year by Apotex.
